Journal article 239 views 45 downloads
Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure
Quality of Life Research, Volume: 34, Issue: 2, Pages: 471 - 484
Swansea University Author:
Juman Al-Dujaili
-
PDF | Version of Record
© The Author(s) 2024. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License (CC-BY 4.0).
Download (1.33MB)
DOI (Published version): 10.1007/s11136-024-03818-6
Abstract
This study aimed to examine the trajectory in health-related quality of life (HRQoL) during and after hospitalisation for worsening of heart failure (HF) in Malaysia. 200 patients with heart failure and reduced ejection fraction (HFrEF) admitted into two hospitals in Malaysia due to worsening of HF...
Published in: | Quality of Life Research |
---|---|
ISSN: | 0962-9343 1573-2649 |
Published: |
Springer Nature
2025
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa68506 |
first_indexed |
2024-12-09T19:47:29Z |
---|---|
last_indexed |
2025-03-19T05:26:40Z |
id |
cronfa68506 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2025-03-18T15:43:27.9016415</datestamp><bib-version>v2</bib-version><id>68506</id><entry>2024-12-09</entry><title>Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure</title><swanseaauthors><author><sid>47d192c8bb46dd4c0cc72bbfea4210ec</sid><ORCID>0000-0002-7515-5344</ORCID><firstname>Juman</firstname><surname>Al-Dujaili</surname><name>Juman Al-Dujaili</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-12-09</date><deptcode>MEDS</deptcode><abstract>This study aimed to examine the trajectory in health-related quality of life (HRQoL) during and after hospitalisation for worsening of heart failure (HF) in Malaysia. 200 patients with heart failure and reduced ejection fraction (HFrEF) admitted into two hospitals in Malaysia due to worsening of HF were surveyed using the EQ-5D-5 L questionnaire. The primary outcomes were utility values at admission, discharge and 1-month post-discharge (1MPD). Secondary outcomes included the visual analogue scores (VAS) and the proportion of patients reporting each EQ-5D-5 L dimension levels. Missing data were imputed using multiple imputation, and generalised linear mixed models were fitted. At admission, the unadjusted mean utility values and VAS scores for HFrEF patients in Malaysia were as low as 0.150 ± 0.393 and 38.2 ± 20.8, respectively. After a median hospital stay of 4 days, there was a significant improvement in utility values and VAS scores by 0.510 (95% CI: 0.455-0.564) and 28.8 (95% CI: 25.5-32.1), respectively. The utility value and VAS score at 1-month post-discharge were not significantly different from discharge. The proportion of HFrEF patients reporting problems and severe problems in mobility, self-care, usual activities, and anxiety/depression, pain/discomfort reduced at varying degree from admission to discharge and 1MPD. HF is a progressive condition with substantial variation in HRQoL during the disease trajectory. During hospitalisation due to worsening of HF, HFrEF population has unfavourable HRQoL. Rapid and significant HRQoL improvement was observed at discharge, which sustained over one month. The study findings can inform future cost-effectiveness analyses and policies.</abstract><type>Journal Article</type><journal>Quality of Life Research</journal><volume>34</volume><journalNumber>2</journalNumber><paginationStart>471</paginationStart><paginationEnd>484</paginationEnd><publisher>Springer Nature</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0962-9343</issnPrint><issnElectronic>1573-2649</issnElectronic><keywords>Heart failure; Health-related quality of life; EQ-5D; Utility; Visual analogue score; Hospitalisation</keywords><publishedDay>28</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2025</publishedYear><publishedDate>2025-02-28</publishedDate><doi>10.1007/s11136-024-03818-6</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Another institution paid the OA fee</apcterm><funders>No funding is available for this study. Open Access funding enabled and organized by CAUL and its Member Institutions.</funders><projectreference/><lastEdited>2025-03-18T15:43:27.9016415</lastEdited><Created>2024-12-09T15:14:46.9510391</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Pharmacy</level></path><authors><author><firstname>Wai Chee</firstname><surname>Kuan</surname><orcid>0000-0002-6243-1194</orcid><order>1</order></author><author><firstname>Ka Keat</firstname><surname>Lim</surname><orcid>0000-0002-2340-4097</orcid><order>2</order></author><author><firstname>Kok Han</firstname><surname>Chee</surname><orcid>0000-0002-4485-0504</orcid><order>3</order></author><author><firstname>Sazzli</firstname><surname>Kasim</surname><orcid>0000-0003-4585-7713</orcid><order>4</order></author><author><firstname>Juman</firstname><surname>Al-Dujaili</surname><orcid>0000-0002-7515-5344</orcid><order>5</order></author><author><firstname>Kenneth Kwing-Chin</firstname><surname>Lee</surname><orcid>0000-0002-2583-0030</orcid><order>6</order></author><author><firstname>Siew Li</firstname><surname>Teoh</surname><orcid>0000-0003-4163-7895</orcid><order>7</order></author></authors><documents><document><filename>68506__33091__764e7c2b62354ba091452fb1e025603b.pdf</filename><originalFilename>68506.VOR.pdf</originalFilename><uploaded>2024-12-09T15:21:07.4584307</uploaded><type>Output</type><contentLength>1391840</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© The Author(s) 2024. Open Access. This article is licensed under a Creative Commons
Attribution 4.0 International License (CC-BY 4.0).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2025-03-18T15:43:27.9016415 v2 68506 2024-12-09 Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure 47d192c8bb46dd4c0cc72bbfea4210ec 0000-0002-7515-5344 Juman Al-Dujaili Juman Al-Dujaili true false 2024-12-09 MEDS This study aimed to examine the trajectory in health-related quality of life (HRQoL) during and after hospitalisation for worsening of heart failure (HF) in Malaysia. 200 patients with heart failure and reduced ejection fraction (HFrEF) admitted into two hospitals in Malaysia due to worsening of HF were surveyed using the EQ-5D-5 L questionnaire. The primary outcomes were utility values at admission, discharge and 1-month post-discharge (1MPD). Secondary outcomes included the visual analogue scores (VAS) and the proportion of patients reporting each EQ-5D-5 L dimension levels. Missing data were imputed using multiple imputation, and generalised linear mixed models were fitted. At admission, the unadjusted mean utility values and VAS scores for HFrEF patients in Malaysia were as low as 0.150 ± 0.393 and 38.2 ± 20.8, respectively. After a median hospital stay of 4 days, there was a significant improvement in utility values and VAS scores by 0.510 (95% CI: 0.455-0.564) and 28.8 (95% CI: 25.5-32.1), respectively. The utility value and VAS score at 1-month post-discharge were not significantly different from discharge. The proportion of HFrEF patients reporting problems and severe problems in mobility, self-care, usual activities, and anxiety/depression, pain/discomfort reduced at varying degree from admission to discharge and 1MPD. HF is a progressive condition with substantial variation in HRQoL during the disease trajectory. During hospitalisation due to worsening of HF, HFrEF population has unfavourable HRQoL. Rapid and significant HRQoL improvement was observed at discharge, which sustained over one month. The study findings can inform future cost-effectiveness analyses and policies. Journal Article Quality of Life Research 34 2 471 484 Springer Nature 0962-9343 1573-2649 Heart failure; Health-related quality of life; EQ-5D; Utility; Visual analogue score; Hospitalisation 28 2 2025 2025-02-28 10.1007/s11136-024-03818-6 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Another institution paid the OA fee No funding is available for this study. Open Access funding enabled and organized by CAUL and its Member Institutions. 2025-03-18T15:43:27.9016415 2024-12-09T15:14:46.9510391 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Pharmacy Wai Chee Kuan 0000-0002-6243-1194 1 Ka Keat Lim 0000-0002-2340-4097 2 Kok Han Chee 0000-0002-4485-0504 3 Sazzli Kasim 0000-0003-4585-7713 4 Juman Al-Dujaili 0000-0002-7515-5344 5 Kenneth Kwing-Chin Lee 0000-0002-2583-0030 6 Siew Li Teoh 0000-0003-4163-7895 7 68506__33091__764e7c2b62354ba091452fb1e025603b.pdf 68506.VOR.pdf 2024-12-09T15:21:07.4584307 Output 1391840 application/pdf Version of Record true © The Author(s) 2024. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License (CC-BY 4.0). true eng http://creativecommons.org/licenses/by/4.0/ |
title |
Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure |
spellingShingle |
Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure Juman Al-Dujaili |
title_short |
Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure |
title_full |
Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure |
title_fullStr |
Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure |
title_full_unstemmed |
Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure |
title_sort |
Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure |
author_id_str_mv |
47d192c8bb46dd4c0cc72bbfea4210ec |
author_id_fullname_str_mv |
47d192c8bb46dd4c0cc72bbfea4210ec_***_Juman Al-Dujaili |
author |
Juman Al-Dujaili |
author2 |
Wai Chee Kuan Ka Keat Lim Kok Han Chee Sazzli Kasim Juman Al-Dujaili Kenneth Kwing-Chin Lee Siew Li Teoh |
format |
Journal article |
container_title |
Quality of Life Research |
container_volume |
34 |
container_issue |
2 |
container_start_page |
471 |
publishDate |
2025 |
institution |
Swansea University |
issn |
0962-9343 1573-2649 |
doi_str_mv |
10.1007/s11136-024-03818-6 |
publisher |
Springer Nature |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Pharmacy{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Pharmacy |
document_store_str |
1 |
active_str |
0 |
description |
This study aimed to examine the trajectory in health-related quality of life (HRQoL) during and after hospitalisation for worsening of heart failure (HF) in Malaysia. 200 patients with heart failure and reduced ejection fraction (HFrEF) admitted into two hospitals in Malaysia due to worsening of HF were surveyed using the EQ-5D-5 L questionnaire. The primary outcomes were utility values at admission, discharge and 1-month post-discharge (1MPD). Secondary outcomes included the visual analogue scores (VAS) and the proportion of patients reporting each EQ-5D-5 L dimension levels. Missing data were imputed using multiple imputation, and generalised linear mixed models were fitted. At admission, the unadjusted mean utility values and VAS scores for HFrEF patients in Malaysia were as low as 0.150 ± 0.393 and 38.2 ± 20.8, respectively. After a median hospital stay of 4 days, there was a significant improvement in utility values and VAS scores by 0.510 (95% CI: 0.455-0.564) and 28.8 (95% CI: 25.5-32.1), respectively. The utility value and VAS score at 1-month post-discharge were not significantly different from discharge. The proportion of HFrEF patients reporting problems and severe problems in mobility, self-care, usual activities, and anxiety/depression, pain/discomfort reduced at varying degree from admission to discharge and 1MPD. HF is a progressive condition with substantial variation in HRQoL during the disease trajectory. During hospitalisation due to worsening of HF, HFrEF population has unfavourable HRQoL. Rapid and significant HRQoL improvement was observed at discharge, which sustained over one month. The study findings can inform future cost-effectiveness analyses and policies. |
published_date |
2025-02-28T08:23:15Z |
_version_ |
1834978845717954560 |
score |
11.062967 |